Newsroom

BigHat founder moderates Deep Life salon

BigHat founder Peyton Greenside moderates Innovation Endeavors' Deep Life Salon panel between biotech founders and pharmaceutical partners from Novozymes and Novo Nordisk on commercializing research.

‍

Posted:

11/11/2019

Read Time:

mins

Words by:

View all news

4.17.2025

BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics

Press

3.4.2025

BigHat’s Next Chapter: A Message from CEO Peyton Greenside

Announcements

11.4.2024

Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

Press

8.13.2024

BigHat featured on Genetic Engineering & Biotechnology News

Announcements

8.5.2024

BigHat named to the 2024’s Fierce Biotech 15

Announcements

6.27.2024

BigHat’s Cofounder and CSO, Peyton Greenside, Joins the Timmerman Traverse for Sickle Forward

Announcements

4.24.2024

BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design

Press

2.27.2024

BigHat’s CIO on Software Engineering Daily podcast

Announcements

12.5.2023

AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies

Press

10.26.2023

BigHat on Genetic Engineering & Biotechnology News

Press

8.2.2023

BigHat’s CSO on Biocom CA’s Lifelines Podcast

Announcements

6.8.2023

BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023

Presentations

Newsroom

BigHat founder moderates Deep Life salon

Read more

Newsroom